In patients with previous myocardial infarction (MI), aggressive hypertension control and low-
density lipoprotein cholesterol (LDL-C) reduction are important secondary prevention …

Background Higher visit-to-visit variability in risk factors such as blood pressure and low-
density lipoprotein (LDL)-cholesterol are associated with an increase in cardiovascular (CV) …

Background A low level of high‐density lipoprotein‐cholesterol (HDL‐C) is a well‐known
risk factor for cardiovascular events. Recent studies have also suggested that HDL‐C …

Background: Studies demonstrate that lowering low-density lipoprotein cholesterol (LDL-C)
using a statin is associated with significant reduction in cardiovascular events. Whether visit …

Objective: Variability in lipid levels has been associated with poor cardiovascular outcomes
in patients with coronary artery disease. The aim of this study was to investigate whether low …

Epidemiologic, genetic, and clinical intervention studies have indisputably shown that low-
density lipoprotein cholesterol (LDL-C) is causal in the development of atherosclerotic …

Background: Risk factor control is the cornerstone of managing stable ischemic heart
disease but is often not achieved. Predictors of risk factor control in a randomized clinical …

Several epidemiologic studies have demonstrated that plasma low-density lipoprotein
cholesterol (LDL-C) profile is a key risk indicator for coronary heart disease (CHD) …

Background Traditional cardiovascular risk factors, such as hypertension and dyslipidemia,
predispose individuals to cardiovascular disease, particularly patients with diabetes. We …

The authors examined the relationship between the magnitude of low‐density lipoprotein
cholesterol (LDL‐C) reduction and the magnitude of cardiovascular risk reduction. From the …